Label Value
DOI 10.1007/s00280-019-03819-0
TITLE An open label phase 1 study evaluation safety, tolerability, and maximum tolerated dose of oral administration of irinotecan in combination with capecitabine
TYPE article
PUBLICATION DATE
Service Status Date Last Checked
Scopus Yes 2019-07-30T04:49:49.458636
Web of Science Yes 2019-07-31T04:45:09.467757
Compendex No 2020-10-15T19:15:32.319055